The Medicines and Healthcare Regulatory Agency (MHRA) said on Thursday that the risk associated with this type of blood clot is "very small" and that the public should continue to take up the vaccine when offered it.
The World Health Organisation and the EU's health watchdog have both deemed the AstraZeneca vaccine safe after fears were raised of the jab having serious side effects.
In a statement it said: "ATAGI considers the benefits of vaccination in protecting people in Australia from Covid-19 outweigh the rare potential risk of these rare blood clotting events, and supports the continued rollout of the AstraZeneca vaccine in Australia".
There were no reports of similar cases after receiving the Pfizer/BioNTech vaccine. Those figures included a "significant" number of the cases reported in Germany but not all, she said.
The woman had a lung embolism and a cerebral haemorrhage, Lareb said.
Vials of AstraZeneca's Covishield vaccine for Covid-19 are seen at a filling lab at the Serum Institute of India, Pune.
However, concerns continue to surface over the rollout of vaccines, with Queensland nearly out of the Pfizer inoculation and unsure when it will receive its next delivery.
Joe Biden "Heartbroken" Over Deadly Attack At US Capitol
But permanent barriers remain in place on all the roadway entrances to the Capitol, well-manned by police and national guard. The law enforcement officials told the AP that the driver then got out of the vehicle with what appeared to be a knife.
Malaysia has agreed to purchase 66.7 million doses of Covid-19 vaccines from various drug makers and plans to vaccinate at least 80% of the population by February next year. "Between day four and day 20, after vaccination, and have generally caused severe symptoms requiring hospitalisation", he said.
Speaking to Reuters, the government's chief medical adviser said USA authorities had secured enough coronavirus inoculations to immunise the entire population and possibly administer booster shots in the autumn.
European and United Kingdom medical regulators are yet to establish a causal link with rare instances of blood clotting disorders and the AstraZeneca jab.
The agency said it had identified 30 cases of rare blood clot events following use of the Oxford/AstraZeneca jab, out of 18.1 million doses administered up to and including March 24.
The European Medicines Agency said its safety committee will probably issue an updated recommendation next week.
Cooke said the agency's assessment was based on 62 cases worldwide of unusual blood clots, including 14 deaths, reported to the EMA by March 22. In late March, CSL Ltd began domestic production of 50 million doses.